Merck & Co., Inc. — Director's Dealing 2019

Feb 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-02-04

Reporting Person: GLOCER THOMAS H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-04	Common Stock	M	5000.0000	$35.1900	Acquired	10100.0000	Direct
2019-02-04	Common Stock	M	5000.0000	$24.3000	Acquired	15100.0000	Direct
2019-02-04	Common Stock	S	10000.0000	$75.9590	Disposed	5100.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-04	Stock Option (right to buy)	$24.3000	M	5000.0000	Disposed	2019-04-30	Common Stock (5000.0000)	Direct
2019-02-04	Stock Option (right to buy)	$35.1900	M	5000.0000	Disposed	2020-08-03	Common Stock (5000.0000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.9500 to $75.9800, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2: The option became exercisable in equal installments on 5/1/2010, 5/1/2011 and 5/1/2012.

F3: The option became exercisable in equal installments on 8/4/2011, 8/4/2012 and 8/4/2013.